Pulse oximetry

Global Patient Monitoring Equipment Market MedSuite Report 2022-2028 - ResearchAndMarkets.com

Retrieved on: 
Monday, August 15, 2022

The "Patient Monitoring Equipment Market Report Suite - Global - 2022-2028 - MedSuite" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Patient Monitoring Equipment Market Report Suite - Global - 2022-2028 - MedSuite" report has been added to ResearchAndMarkets.com's offering.
  • Electromyogram Monitoring Market- MedCore - The Electromyogram Monitoring market consists of EMG Monitor and EMG Consumables market segments.
  • Pulse Oximetry Monitoring Market - MedCore - The Pulse Oximetry Monitoring market is further divided into Hospital-based, Alternate-care, and OEM Circuit Board market segments.
  • Blood Pressure Monitoring Market - MedCore - The Blood Pressure Monitoring market is an umbrella term for Personal and Professional Monitoring devices.

Garmin Enduro 2 ultraperformance smartwatch adds mapping, touchscreen and its longest-ever battery life

Retrieved on: 
Tuesday, August 9, 2022

Garmin International, Inc., a unit of Garmin Ltd. (NYSE: GRMN), today announced the Enduro 2 ultraperformance multisport GPS smartwatch.

Key Points: 
  • Garmin International, Inc., a unit of Garmin Ltd. (NYSE: GRMN), today announced the Enduro 2 ultraperformance multisport GPS smartwatch.
  • Now with built-in mapping, music, Garmin best-in-class battery life and growing list of performance features, Enduro 2 is a must-have for any endurance athlete.
  • During the day, Enduro 2 harnesses the suns energy to provide battery life of up to 150 hours in GPS mode and up to 46 days in smartwatch mode.
  • Garmin is a registered trademark and Enduro, Garmin Pay, Health Snapshot, NextFork, Power Sapphire and SatIQ are trademarks of Garmin Ltd. or its subsidiaries.

Provepharm announces that it has received FDA approval for BLUDIGOTM (Indigotindisulfonate Sodium, USP) Injection.

Retrieved on: 
Tuesday, July 12, 2022

MARSEILLE, France and COLLEGEVILLE, Pa., July 12, 2022 /PRNewswire/ -- Provepharm, a French company with operations in the United States of America, specializing in the development of pharmaceutical applications, today announced that it has received FDA New Drug Approval for the marketing of its injectable BLUDIGO™ (Indigotindisulfonate Sodium) Injection. BLUDIGO™ is a diagnostic dye indicated for use as a visualization aid in the cystoscopic assessment of the integrity of the ureters in adults following urological and gynecological open, robotic, or endoscopic surgical procedures.

Key Points: 
  • Provepharm filed its application for approval with the FDA in September 2021 and with this new approval, its US affiliate, Provepharm Inc., will market the product directly in the United States of America.
  • Frederick Girard, Provepharm's Chief Medical Officer, said: "BLUDIGOTM is the second product to be granted market authorization by the FDA from Provepharm's R&D group.
  • In addition, Mary Jane Helenek, Executive VP and COO of Provepharm, Inc., said: "Provepharm is immensely proud of this accomplishment and approval by the FDA.
  • Eighty-two percent of ureter injuries occur during pelvic surgery, and75%of urinary tract injuries are due to gynecologic surgery [1].

SPRING Vision announces investment by MediPress Health Limited Partnership

Retrieved on: 
Tuesday, July 5, 2022

HAIFA, Israel , July 5, 2022 /PRNewswire/ -- SPRING Vision, developing a technology for noninvasive, real-time, multispectral retinal imaging for automated diagnostics of ocular and systemic diseases, announces investment by MediPress, a public R&D Life Science limited partnership (TASE: MPRS) that invests in medical R&D companies specializing in digital and advanced technologies.

Key Points: 
  • HAIFA, Israel, July 5, 2022 /PRNewswire/ -- SPRING Vision ,developing a technology for noninvasive, real-time, multispectral retinal imaging for automated diagnostics of ocular and systemic diseases, announces investment by MediPress , a public R&D Life Science limited partnership (TASE: MPRS) that invests in medical R&D companies specializing in digital and advanced technologies.
  • Noam Allon, CEO of SPRING Vision: "We are proud to be chosen by MediPress, a professional, selective fund, led by highly experienced medical executives.
  • We appreciate this vote of confidence, and I believe that this is an important next step for SPRING Vision."
  • The human retina is a map of crucial information of bodily health conditions, and SPRING Vision uses it to gather vital data.

GE Healthcare, Medtronic Partnership Accelerates Global Access to Personalized Care by Delivering Advanced Patient Monitoring Solutions on the CARESCAPE Platform

Retrieved on: 
Wednesday, June 1, 2022

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220601005454/en/
    Our longstanding collaboration with Medtronic allows GE Healthcare to integrate clinically advanced parameters to enable clinicians with precision monitoring for individualized care, said Neal Sandy, general manager for Monitoring Solutions at GE Healthcare.
  • Since before the inception of the CARESCAPE platform, Medtronic solutions have been integrated into GE Healthcare technologies for comprehensive patient monitoring.
  • Bringing the new INVOS technology into the CARESCAPE platform will add ergonomic benefits, enhance ease of use and improve workflow.
  • About the Patient Monitoring Operating Unit at Medtronic:
    With patient safety at our core, the Patient Monitoring business develops technologies that provide clinicians with actionable insights to personalize care.

Harness the power of the sun with the Forerunner 955 Solar from Garmin

Retrieved on: 
Wednesday, June 1, 2022

Garmin International, Inc., a unit of Garmin Ltd. (NYSE: GRMN), today announced the Forerunner 955 Solar , its first dedicated running smartwatch with solar charging.

Key Points: 
  • Garmin International, Inc., a unit of Garmin Ltd. (NYSE: GRMN), today announced the Forerunner 955 Solar , its first dedicated running smartwatch with solar charging.
  • Featuring a Power Glass solar charging lens, the Forerunner 955 Solar gives athletes up to 20 days of battery life in smartwatch mode1 and up to 49 hours in GPS mode2.
  • With high-end training features and performance metrics, the Forerunner 955 Solar gives you the tools to chase your goals.
  • No matter where, when or why you run, the Forerunner 955 Solar will help you go the extra mile.

Garmin celebrates Global Running Day with the introduction of the Forerunner 255 series

Retrieved on: 
Wednesday, June 1, 2022

Garmin unveiled the Forerunner 255 series in conjunction with Global Running Day, an annual celebration of the sport of running that encourages athletes of all levels to make a life-changing commitment to running.

Key Points: 
  • Garmin unveiled the Forerunner 255 series in conjunction with Global Running Day, an annual celebration of the sport of running that encourages athletes of all levels to make a life-changing commitment to running.
  • View the full release here: https://www.businesswire.com/news/home/20220601005012/en/
    Introducing the Forerunner 255 series from Garmin (Photo: Business Wire)
    Designed for runners by runners, the Forerunner 255 series of GPS running smartwatches are loaded with features and training tools to help you compete at a higher level, said Dan Bartel, Garmin vice president of global consumer sales.
  • Offering personalized training and recovery insights, the Forerunner 255 series includes performance monitoring tools to help athletes push the limits.
  • Garmin, Forerunner and Tacx are registered trademarks and Garmin Connect, Trendline, Pace Pro, Garmin Pay, Firstbeat Analytics and Body Battery are trademarks of Garmin Ltd. or its subsidiaries.

Simple and streamlined, Garmin vívosmart 5 fitness tracker is the effortless way to take charge of your everyday health, wellness and activity

Retrieved on: 
Wednesday, April 20, 2022

With a rounded band designed to fit around the curves of your wrist, the vvosmart 5 is built for comfort, especially important for sleep tracking.

Key Points: 
  • With a rounded band designed to fit around the curves of your wrist, the vvosmart 5 is built for comfort, especially important for sleep tracking.
  • Compared to its predecessor, the vvosmart 5 features a bright, 66% larger display with larger text and an easy-to-use touchscreen and button interface.
  • Whats more, the vvosmart 5 gives alerts for abnormally high and low heart rates that have been configured by the user.
  • Garmin and vvosmart are registered trademarks and Body Battery and Elevate are trademarks of Garmin Ltd. or its subsidiaries.

MESI joins forces with WEDA medical management software provider for early disease detection in France

Retrieved on: 
Tuesday, April 5, 2022

To take early disease discovery to a new level, it joined forces with the French subsidiary of the Slovenian company MESI, Ltd .

Key Points: 
  • To take early disease discovery to a new level, it joined forces with the French subsidiary of the Slovenian company MESI, Ltd .
  • This is the developer of the MESI mTABLET a digital solution combining diverse diagnostic measurements, patient records and medical apps.
  • The two systems have been successfully integrated, so the MESI mTABLET measurements can now be ordered from the WEDA software and instantly stored into WEDA patient files.
  • WEDA, a leader in medical management software in France with over 15,000 users, and MESI, Ltd., an innovator in digital diagnostics, interconnected their systems to change that in French healthcare.

MESI joins forces with WEDA medical management software provider for early disease detection in France

Retrieved on: 
Tuesday, April 5, 2022

To take early disease discovery to a new level, it joined forces with the French subsidiary of the Slovenian company MESI, Ltd .

Key Points: 
  • To take early disease discovery to a new level, it joined forces with the French subsidiary of the Slovenian company MESI, Ltd .
  • This is the developer of the MESI mTABLET a digital solution combining diverse diagnostic measurements, patient records and medical apps.
  • The two systems have been successfully integrated, so the MESI mTABLET measurements can now be ordered from the WEDA software and instantly stored into WEDA patient files.
  • WEDA, a leader in medical management software in France with over 15,000 users, and MESI, Ltd., an innovator in digital diagnostics, interconnected their systems to change that in French healthcare.